Delivery Order SPE2DB22D3016-SPE2DB25FBHP2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $18,314.10 to AmerisourceBergen Drug Corp for the supply of Gamunex-C 10 gram/100 mL vials on August 27, 2025, with an ultimate completion date of September 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The contract will be performed at...
- The Defense Logistics Agency awarded a $13,963.20 delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 40 Gram/400 mL vials on August 15, 2025, with completion expected by September 8, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $18,882.24 to AmerisourceBergen Drug Corp for the supply of Gamunex-C 20 gram/200 mL vials on September 12, 2025. This firm fixed price, competitively awarded delivery order is scheduled for completion by October 3, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's proven capability to compete successfully in...
- The Defense Logistics Agency awarded a $23,602.80 delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 mL vials on September 4, 2025, with completion targeted for September 25, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a $11,636 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Gamunex-C 40 gram/400 mL vials. This non-competitive delivery order is scheduled for completion by September 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $28,323.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of GAMUNEX-C 20 gram/200 mL vials. This non-set-aside competitive award is scheduled for completion by September 2, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9...
- The Defense Logistics Agency awarded a $6,073.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C (5 gram/50 mL vial), a pharmaceutical product for federal medical supply needs. This non-competitive delivery order, issued on September 10, 2025, with an ultimate completion date of October 1, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The work will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Gamunex-C 5 gram/50 milliliter vials with a ceiling value of $1,214.68. This is a firm fixed-price delivery order without set-aside designation, with an ultimate completion date of September 15, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,937.12 to AmerisourceBergen Drug Corp for GAMUNEX-C 1 gram/10 milliliter vials on August 19, 2025, with completion targeted for September 10, 2025. This firm fixed price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a comprehensive global...
- The Defense Logistics Agency awarded a $7,080.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 mL vials with a completion date of August 28, 2025. This non-set-aside award was issued on August 7, 2025, and represents a pharmaceutical supply delivery executed through AmerisourceBergen's existing contract vehicle with DLA. The product will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBHP2Delivery Order
The Defense Logistics Agency awarded a $13,861.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Gamunex-C 10 gram/100 ml vials. The contract is scheduled for completion by September 29, 2025, with performance taking place at the contractor's location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. This award operates under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion vehicle valued through December 2026 that serves as the primary pharmaceutical support mechanism for military healthcare programs worldwide. As a leading pharmaceutical distributor and critical vendor in the federal medical supply chain, AmerisourceBergen supplies a broad portfolio of medications, vaccines, and medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contracting history demonstrates consistent performance in delivering both brand-name and generic pharmaceuticals through competitively awarded delivery orders with firm fixed pricing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.9k | 9/8/25 |